< Back to previous page
Researcher
Chantal Mathieu
- Disciplines:Endocrinology and metabolic diseases
Affiliations
- Clinical and Experimental Endocrinology (Division)
Member
From1 Oct 1999 → Today
Projects
41 - 50 of 75
- Ontrafelen van de mechanismen nodig om autoreactieve T-cell reactiviteit te onderdrukken tijdens macrofaag-apoptotische beta cel interactieFrom1 Jan 2015 → 31 Dec 2017Funding: FWO research grant KAN
- Is PFKFB4 a metabolic checkpoint controlling 1,25(OH)2D3-modulated dendritic cell (DC) tolerogenicity?From1 Jan 2015 → 31 Dec 2017Funding: FWO research grant KAN
- A novel L. lactis-based antigen-specific platform for the treatment of type 1 diabetes: essential steps towards successful clinical translation.From1 Sep 2014 → 6 Dec 2019Funding: FWO fellowships
- Diabetes management for residential care centers residents - researching and setting up a shared care modelFrom30 Jun 2014 → 31 Oct 2016Funding: IWT / VLAIO - Experimental garden Building Industry
- Automated platform for high-throughput microbiome analysisFrom26 Jun 2014 → 25 Dec 2018Funding: Hercules - Small and Medium size research infrastructure
- Dialogue between the B-cell and macrophage as starting point for autoimmune type 1 diabetesFrom1 Jun 2014 → 17 Sep 2017Funding: FWO fellowships
- Prediction of pregnancy outcomes in women with gestational diabetes and their risk to develop diabetes postpartum.From1 Jan 2014 → 31 Dec 2017Funding: FWO research project (including WEAVE projects)
- Platform Innovage.From1 Nov 2013 → 31 Oct 2016Funding: IWT / VLAIO - Experimental garden Building Industry
- Diabetes reversal in NOD mice by L.lactis-based Ag therapy in combination with low dose anti-CD3.From1 Oct 2013 → 30 Sep 2014Funding: BOF - Other initiatives
- The beta-cell and the immune system in type 1 diabetes: partners in crime - developing new therapies in type 1 diabetes through better understanding of beta-cell behaviour and use of novel immunomodulators.From1 Oct 2013 → 30 Sep 2018Funding: BOF - Concerted Research Project from 1994
Publications
1 - 10 of 713
- Effectiveness of a blended mobile-based lifestyle intervention in women with glucose intolerance after a recent history of gestational diabetes (MELINDA): a 1-year, prospective, multicentre, randomised controlled trial.(2024)
Authors: Chantal Mathieu, Christophe Matthys, Annick Bogaerts, Katrien Fouzia Benhalima
Pages: 102523 - Continuous Glucose Monitoring-Based Metrics and Hypoglycemia Duration in Insulin-Experienced Individuals With Long-standing Type 2 Diabetes Switched From a Daily Basal Insulin to Once-Weekly Insulin Icodec: Post Hoc Analysis of ONWARDS 2 and ONWARDS 4.(2024)
Authors: Chantal Mathieu
Pages: 729 - 738 - The Health Economics of Automated Insulin Delivery Systems and the Potential Use of Time in Range in Diabetes Modeling: A Narrative Review(2024)
Authors: Chantal Mathieu, Pieter Gillard
Pages: 66 - 75 - CD4+ T cells from individuals with type 1 diabetes respond to a novel class of deamidated peptides formed in pancreatic islets.(2024)
Authors: Rita Derua, Chantal Mathieu, Lut Overbergh
Pages: db230588 - The double burden: Navigating type 1 diabetes and obesity(2024)
Authors: Nele Steenackers, Chantal Mathieu, Bart Van Der Schueren
- Type 1 diabetes mellitus: a brave new world(2024)
Authors: Chantal Mathieu
Pages: 71 - 72 - Clinical care advice for monitoring of islet autoantibody positive individuals with presymptomatic type 1 diabetes(2024)
Authors: Kristina Casteels, Chantal Mathieu
- An Insulin-Chromogranin A Hybrid Peptide activates DR11 restricted T cells in human type 1 diabetes.(2024)
Authors: Chantal Mathieu, Lut Overbergh
Pages: db230622 - A first-in-human, open-label Phase 1b and a randomised, double-blind Phase 2a clinical trial in recent-onset type 1 diabetes with AG019 as monotherapy and in combination with teplizumab(2024)
Authors: Chantal Mathieu
- Hypoglycaemia after Initiation of CFTR Modulator Therapy in a Cystic Fibrosis Patient without Diabetes(2023)
Authors: Lieven Dupont, Natalie Lorent, Pieter Gillard, Bart Van Der Schueren, Ann Mertens, Chantal Mathieu, Roman Vangoitsenhoven
Patents
1 - 6 of 6
- Biomarkers for diabetes therapy (Inventor)
- Biomarkers for diabetes therapy (Inventor)
- Improved methods for pancreatic islet transplantation (Inventor)
- Citrullinated peptides for diagnosis or treatment of diabetes (Inventor)
- Improved methods for pancreatic islet transplantation (Inventor)
- RESISTANCE TO OXIDATIVE STRESS (Inventor)